Dihydroergotamine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Dihydroergotamine. Educational only — not medical advice.
Labeled uses
Dihydroergotamine mesylate nasal spray is indicated for the acute treatment of migraine headaches with or without aura. Dihydroergotamine mesylate nasal spray is not intended for the prophylactic therapy of migraine or for the management of hemiplegic or basilar migraine.
Source: FDA labeling via NIH DailyMed (set 9ffe6d5a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.